Exact(1)
However, changes in common to caveolin-1 expression and G protein signalling, through attenuation of Rgs2 and Rgs5, may contribute to hypertension through augmentation of vasoconstrictor pathways and provide potential targets for common drug development.
Similar(59)
Indeed, we wish to find optimal therapies while exposing the fewest patients to the failures that are common in drug development.
Drug-induced arrhythmia is one of the most common causes of drug development failure and withdrawal from market.
As individualized targeted therapeutic approaches have become more common in NSCLC drug development, models that reflect the patient heterogeneity and faithfully recapitulate the in vivo tumor biology are crucial to improve prediction of clinical efficacy of novel therapies and to reduce the attrition rate in oncology 11.
This group of clinicians and scientists with a common interest in pediatric drug development and medicines-use systems developed a framework for developing drugs in dosage forms suitable for use in pediatric patients (Fig. 1).
A group of clinicians and scientists with a common interest in pediatric drug development and medicines-use systems developed a practical framework for identifying a list of active pharmaceutical ingredients (APIs) with the greatest market potential for development to use in pediatric patients.
The example represents a common scenario in clinical drug development where dosing projections are required.
In fact, thermal stability is a well-known common problem in protein drug development.
Clinical trial guidelines have been developed to attain common standards across phases of drug development and disparate sites [ 28].
Its inhibition protects initiation of RAS signaling, and it is one of the common targets considered for oncological drug development.
The analysis was completed in one day — as opposed to years, which is common using traditional methods of drug development.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com